When Aleve, the much-heralded nonprescription version of naproxen sodium, made the over-the-counter switch in June 1994, it was the biggest thing to hit the analgesics market since ibuprofen made the switch a decade earlier. Some analysts had projected that the OTC product, manufactured by Syntex Corp. and marketed by Procter & Gamble Co., would add $200 million to the $2.5 billion-plus analgesics market. Fifteen months later, supermarket retailers are scratching their heads, unable to ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.